Furthermore, based on TCGA datasets, patients with ESCC carrying KMT2B, KMT2C or KMT2D mutations showed slightly lower NORAD expression, but the difference was not significant (Fig. 3d). The gene discussed is KMT2B; the disease is esophageal squamous cell carcinoma.